vTv Therapeutics (VTVT) Treasury Shares (2015 - 2019)
vTv Therapeutics (VTVT) posted Treasury Shares of $11667.0 for Q4 2019, little changed sequentially from $11667.0 in Q3 2019, and down 50.0% YoY from $23333.0 in Q4 2018.
vTv Therapeutics (VTVT) Treasury Shares (2015 - 2019) Analysis & Trends
vTv Therapeutics has reported Treasury Shares for 4 years, with the latest figure at $11667.0 in Q4 2019.
- Quarterly Treasury Shares fell 50.0% year-over-year to $11667.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $11667.0 (down 50.0% YoY) and the FY2019 annual result came in at $11667.0, down 50.0% from the prior year.
- Treasury Shares steadied at $11667.0 in Q4 2019 per VTVT's latest filing, from $11667.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $49.8 million in Q2 2015 and troughed at $11667.0 in Q1 2019.
- A 4-year average of $3.6 million and a median of $23333.5 in 2018 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2018 and 2019: Treasury Shares slumped 33.33% in 2018, then plunged 50.0% in 2019.
- Over 4 years, Treasury Shares stood at $831934.0 in 2015, then slumped by 95.79% to $35000.0 in 2017, then slumped by 33.33% to $23333.0 in 2018, then slumped by 50.0% to $11667.0 in 2019.
- According to Business Quant data, Treasury Shares over the past three periods registered $11667.0, $11667.0, and $11667.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | vTv Therapeutics | 373.77 Mn | 373.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 11,667.00 |
| Dec 31, 2019 | 11,667.00 |
| Sep 30, 2019 | 11,667.00 |
| Sep 30, 2019 | 11,667.00 |
| Jun 30, 2019 | 11,667.00 |
| Jun 30, 2019 | 11,667.00 |
| Mar 31, 2019 | 11,667.00 |
| Mar 31, 2019 | 11,667.00 |
| Dec 31, 2018 | 23,333.00 |
| Dec 31, 2018 | 23,333.00 |
| Sep 30, 2018 | 23,333.00 |
| Sep 30, 2018 | 23,333.00 |
| Jun 30, 2018 | 23,333.00 |
| Jun 30, 2018 | 23,333.00 |
| Mar 31, 2018 | 23,334.00 |
| Mar 31, 2018 | 23,334.00 |
| Dec 31, 2017 | 35,000.00 |
| Dec 31, 2017 | 35,000.00 |
| Sep 30, 2017 | 35,000.00 |
| Sep 30, 2017 | 35,000.00 |